Homologous recombination deficiency predicts response to platinum-based neoadjuvant chemotherapy in early-stage triple-negative breast cancer patients: Secondary analysis of the neocart randomized clinical trial.
JOURNAL OF CLINICAL ONCOLOGY（2022）
关键词
neoadjuvant chemotherapy,homologous recombination deficiency,breast cancer,platinum-based,early-stage,triple-negative
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要